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Discussion
Isonicotinic acid hydrazide (INH) and its N′-arylidene derivatives were early recognized as e ective antitubercular drugs 
Atom Site
In addition, derivatives of adamantane have long been known for their diverse chemotherapeutic activities such as antiviral [6] [7] [8] [9] [10] , anticancer [11] , antibacterial [12] [13] [14] and antitubercular [15, 16] agents. In continuation to our ongoing interest in the structural and pharmacological properties of adamantane derivatives [9, [12] [13] [14] , we synthesized the title compound as hybrid INH-adamantane molecule with potential chemotherapeutic activity. The crystal structure of title compound contains one molecule in the asymmetric unit. The molecule is a functionalized hydrazine with 4-pyridinoyl and adamantyl substituents attached to the two hydrazine nitrogen atoms, N1 and N2. The molecules packing in the crystal structure is stabilized by four intermolecular hydrogen bonds, of which O1 and N1 work as hydrogen bond acceptors and N2, C1 and C13 work as hydrogen bond donors. The distance of the interactions between N2-H1· · · N1 is 2.27 (2) Å, C1-H1A· · · N1 is 2.45 Å, C1-H1A· · · O1 is 2.46 Å and C13-H13A· · · O1 is 2.51 Å and the angles are 163°, 157°, 136°, and 159°, respectively.
